Efficacy of the phosphodiesterase-4 inhibitor, apremilast, in a patient with severe alopecia areata

被引：0
|
作者：
Moe Sakakibara
Harunari Shimoyama
Mami Nomura
Chikako Nakashima
Megumi Hirabayashi
Yoshihiro Sei
Yoshihiro Kuwano
机构：
[1] Teikyo University School of Medicine,Department of Dermatology, Mizonokuchi Hospital
来源：
European Journal of Dermatology | 2019年 / 29卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：436 / 437
页数：1
相关论文
共 50 条
  • [41] The role of the phosphodiesterase-4 inhibitor, roflumilast, in chronic obstructive pulmonary disease
    Wedzicha, Jadwiga A.
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2010, 120 (1-2): : 9 - 10
  • [42] Clinical Efficacy of a Selective Phosphodiesterase-4 Inhibitor (Roflumilast) in Patients with Chronic Obstructive Pulmonary Disease and Metabolic Syndrome
    Ignatova, G.
    Blinova, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [43] Efficacy of apremilast, an oral phosphodiesterase 4 inhibitor, for palmoplantar psoriasis in patients with moderate to severe plaque psoriasis in phase 2 and phase 3 (ESTEEM) trials
    Bissonnette, Robert
    Cather, Jennifer
    Rich, Phoebe
    Menter, Alan
    Ferrandiz, Carlos
    Goodfield, Mark
    Hu, ChiaChi
    Day, Robert
    Sebastian, Michael
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB234 - AB234
  • [44] Efficacy and safety of four doses of CHF6001, a novel inhaled phosphodiesterase-4 inhibitor (PDE4i), in patients with moderate-to-severe COPD
    Singh, Dave
    Nandeuil, Marie Anna
    Pigeon-Francisco, Catherine
    Emirova, Aida
    Santoro, Debora
    Biondaro, Sonia
    Govoni, Mirco
    Petruzzelli, Stefano
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [45] Dual efficacy of dupilumab in a patient with concomitant atopic dermatitis and alopecia areata
    Darrigade, A. -S.
    Legrand, A.
    Andreu, N.
    Jacquemin, C.
    Boniface, K.
    Taieb, A.
    Seneschal, J.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (02) : 534 - 536
  • [46] Equine metabolic investigation of the phosphodiesterase-4 inhibitor ibudilast as a potential performance enhancer
    Philip, Moses
    Kal, Abdul Khader Karakka
    Subhahar, Michael Benedict
    Karatt, Tajudheen K.
    Graiban, Fatma Mohammed
    Ajeebsanu, Meleparappil Muhammed
    Joseph, Marina
    Jose, Shantymol V.
    RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2024, 38 (23)
  • [47] Roflumilast, a phosphodiesterase-4 inhibitor, induces phagocytic activity in Greek COPD patients
    Porpodis, Konstantinos
    Domvri, Kalliopi
    Zarogoulidis, Paul
    Petridis, Dimitrios
    Tsirgogianni, Katerina
    Papaioannou, Antonis
    Hatzizisi, Olga
    Kioumis, Ioannis
    Liaka, Alexandra
    Kikidaki, Violeta
    Lampaki, Sofia
    Organtzis, John
    Zarogoulidis, Konstantinos
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 : 1123 - 1128
  • [48] Investigation Into the Equine Metabolism of Phosphodiesterase-4 Inhibitor Roflumilast for Potential Doping Control
    Philip, Moses
    Kal, Abdul Khader Karakka
    Subhahar, Michael Benedict
    Karatt, Tajudheen K.
    Graiban, Fatma Mohammed
    Ajeebsanu, Meleparappil Muhammed
    Joseph, Marina
    Jose, Shantymol V.
    DRUG TESTING AND ANALYSIS, 2024,
  • [49] Apremilast, an oral phosphodiesterase 4 inhibitor, in a tertiary-referral psoriasis service
    Foulkes, A.
    Nemazee, L.
    Griffiths, C. E. M.
    Warren, R.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 : 74 - 74
  • [50] Clinical anti-inflammatory efficacy of arofylline. a new selective phosphodiesterase-4 inhibitor, in dogs with atopic dermatitis
    Ferrer, L
    Alberola, J
    Queralt, M
    Brazís, P
    Rabanal, R
    Llenas, J
    Puigdemont, A
    VETERINARY RECORD, 1999, 145 (07) : 191 - 194
12345